P. WinichagoonS. FucharoenP. WasiMahidol University2018-10-122018-10-121981-12-01Southeast Asian Journal of Tropical Medicine and Public Health. Vol.12, No.4 (1981), 556-560003836192-s2.0-0019723224https://repository.li.mahidol.ac.th/handle/20.500.14594/30215Examination for circulating platelet aggregates according to Wu and Hoak revealed increased circulating platelet aggregates in 71% of splenectomized and 35% of nonsplenectomized patients with β°-thalassaemia/Hb E disease. This may be causally related to the newly observed high incidences of pulmonary artery thrombosis and hypoxaemia in splenectomized thalassaemic patients. It is recommended that anti-platelet aggregation drugs such as aspirin and/or dipyridamole are given to thalassaemic patients after splenectomy.Mahidol UniversityMedicineArticleSCOPUS